News · PureCycle Technologies, Inc. (PCT) · Industrials

PureCycle falls 32.6% after third-quarter results cite production and regulatory setbacks

Session of November 5, 2026 · Published November 6, 2026 · 3 min read

What happened

PureCycle fell 32.6% on November 5, 2026, because third-quarter results missed revenue expectations and the company disclosed production and regulatory setbacks. PureCycle (PCT) reported earnings per share of $-0.29 against $-0.26 expected on November 4, 2026, 13.0% below estimates. Management said operational problems at its Ironton facility and a regulatory delay in New Jersey reduced production and disrupted sales. Company officials said those issues have been resolved but that PureCycle no longer expects to reach its previously disclosed 2026 production and sales exit rate. The miss and the production constraints were reported by GlobeNewsWire and Seeking Alpha, and PRNewsWire separately detailed the earlier market reaction and an investor notice indicating a pending investigation.

Closing price over the last 30 trading sessions. On November 5, 2026, PCT closed at $1.88, down 32.6% on the day and 62.5% lower than 30 sessions earlier.

How big was the move

The stock closed at $1.88 after falling 32.6% on the day. It fell 43.5% over the last five sessions and opened 17.2% below the previous close on November 5, 2026. Trading volume was 5.2 times its 20-day average, and the move was 5.1 times a typical daily move for this stock. The drop was 27.9 percentage points worse than the Industrials sector median, while the Industrials sector median on the day fell 4.7% and the S&P 500 fell 4.4%.

Each bar is one day's price change; the outlined bar is November 5, 2026. A typical daily move over the past year was 5.2%, so the latest move equals 6.3 times that. Moves outside the dashed lines (about 10.4%) are unusual.

The company’s market value stood at $675.0 million. That level, combined with the outsized one-day decline, underscored how investors penalized the operational setbacks and the withdrawal of 2026 production guidance.

The technical picture

Technically, the stock is weak across short and long horizons. The stock is 38.5% below its 20-day moving average, 57.9% below its 50-day moving average and 73.6% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend, and the Relative Strength Index (14 days) is 20, below the commonly used oversold threshold of 30. The stock is 86.8% below the 52-week high.

Closing price over the past year. PCT ends the period 86.5% below its 52-week high, below its 50-day average ($4.47) and below its 200-day average ($7.13).

Shorter-term returns are deeply negative: the stock fell 50.5% over one month, fell 73.9% over three months and fell 81.4% over one year. Volatility is elevated, with 101% annualized over 60 days, higher than 82% of its own readings over five years, and the stock’s market sensitivity is a beta of 2.60.

Fundamentals and valuation

Over the four quarters through September 30, 2026, PureCycle reported revenue of $13.7 million, which grew 141.7% from a year earlier but reflected operational disruptions in the most recent quarter. Diluted earnings per share for that period were $-1.03 and gross margin was 792.6% (a year earlier: 1893.1%). Operating margin was 929.9% (a year earlier: 2781.5%). Free-cash-flow margin was 1527.7% and return on invested capital was 18.1%.

Quarterly revenue by period end. The latest quarter brought $2M, 3.3% less than the same quarter a year earlier.

The company’s share count over one year increased by 9.0%. On a valuation basis, the stock shows a free-cash-flow yield of 31.0%. PromtFinance scores rank the company very weak on Value (3) and Quality (3), with Momentum at 1 (Very weak) and Growth at 49 (Neutral), suggesting investors and models view the business as high risk despite some cash-flow metrics.

Earnings and analyst expectations

The last report, filed on November 4, 2026, showed earnings per share of $-0.29 against $-0.26 expected, 13.0% below estimates. The average surprise over the last four reports is 31.4% below estimates, and the stock has recorded 0 consecutive quarters beating estimates. The typical two-day reaction after recent reports was that the stock fell 4.2%.

Diluted earnings per share by quarter. The latest quarter shows $0.03, against -$0.18 in the same quarter a year earlier.

Analysts’ consensus rating is Buy, with a consensus price target of $13.67, which is 627.1% above the closing price, based on nine analysts covering the stock and 56% of ratings as Buy or Strong Buy. The company’s next report is scheduled for February 25, 2027.

What to watch

November 4, 2026: last report with earnings per share of $-0.29 against $-0.26 expected, 13.0% below estimates
February 25, 2027: next scheduled earnings report
The company statement that it no longer expects to reach its previously disclosed 2026 production and sales exit rate (management disclosure)
Trading volume at 5.2 times its 20-day average on November 5, 2026
Market value of $675.0 million

Full PCT analysis: scores, chart and financials →